|
Market Closed -
Toronto S.E.
22:35:56 10/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.4500 CAD | -2.17% |
|
-4.26% | -1.10% |
| 08-27 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 08-20 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.6667 | +48.15% | 3 | ||||||
| 58.56 | +97.5% | 16 | ||||||
| 3,035 | +21.94% | 10 | ||||||
| 4.621 | +79.67% | 15 | ||||||
| 31.29 | +38.02% | 13 | ||||||
| 120.63 | +31.62% | 9 | ||||||
| 23.75 | +32.31% | 8 | ||||||
| 311.14 | +60.09% | 7 | ||||||
| 48.83 | +11.42% | 6 | ||||||
| - | - | 1,415 | +216.55% | 1 | ||||
| 36.36 | +40.48% | 7 | ||||||
| 87.5 | +59.38% | 10 | ||||||
| 13.19 | +19.04% | 5 | ||||||
| 49.2 | +26.94% | 8 | ||||||
| 1,013.14 | +53.96% | 7 | ||||||
| - | 92.5 | +24.75% | 2 | |||||
| Average | 396.34 | +53.86% | 8 | ||||||
| Weighted average by Cap. | 515.78 | +65.36% | 11 |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
